Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0EFSRN
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
ZA202500415A-ADC Example 2
|
|||||
| Synonyms |
ZA202500415A-ADC Example 2
Click to Show/Hide
|
|||||
| Organization |
MYRICX PHARMA LIMITED | IMPERIAL COLLEGE INNOVATIONS LIMITED
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
5
|
|||||
| Structure |
|
|||||
| Antibody Name |
Rituximab
|
Antibody Info | ||||
| Antigen Name |
B-lymphocyte antigen CD20 (MS4A1)
|
Antigen Info | ||||
| Payload Name |
NMT inhibitor 1
|
Payload Info | ||||
| Therapeutic Target |
N-Myristoyltransferase (NMT)
|
Target Info | ||||
| Linker Name |
ZA202500415A-ADC-Example-1-Linker
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||